New York Life Investment Management’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Buy
6,768
+239
+4% +$35.3K 0.01% 710
2026
Q1
$938K Buy
6,529
+1,648
+34% +$271K 0.01% 680
2025
Q4
$850K Buy
+4,881
New +$896K 0.01% 642
2023
Q1
– Sell
-6,458
Closed -$563K – 1280
2022
Q4
$563K Buy
6,458
+726
+13% +$65.3K 0.01% 822
2022
Q3
$432K Buy
5,732
+421
+8% +$34.1K 0.01% 870
2022
Q2
$419K Buy
+5,311
New +$444K ﹤0.01% 896

Other funds holding HLI

New York Life Investment Management's HLI Position: Q2 2026 in Review

New York Life Investment Management increased its Houlihan Lokey (HLI) stake by 3.7% in Q2 2026, buying an estimated $35.3K and bringing the position to 6,768 shares worth $908K. The position accounts for 0.01% of the portfolio, ranked #710.

New York Life Investment Management first reported a position in HLI in Q2 2022 and has held it in 6 quarters since. The position peaked at $938K in Q1 2026. 519 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • New York Life Investment Management held 6,768 shares of Houlihan Lokey worth $908K as of Q2 2026.
  • New York Life Investment Management bought 239 Houlihan Lokey shares in Q2 2026, an estimated $35.3K.
  • Houlihan Lokey made up 0.01% of New York Life Investment Management's portfolio in Q2 2026, its #710 holding.
  • New York Life Investment Management first reported a position in Houlihan Lokey in Q2 2022 and has held it in 6 quarters since.
  • New York Life Investment Management's Houlihan Lokey position peaked at $938K in Q1 2026.
  • 519 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.